Open AccessEfficacy and Prognostic Factors for Response to PD-1 Inhibitors in Advanced Cervical Carcinoma: A Retrospective Study
Author(s) -
Mingxia Cheng,
Haihong Wang,
Yingchao Zhao,
Guiling Li
Publication year - 2022
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s358302
Subject(s) - medicine , oncology , cervical cancer , leukopenia , adverse effect , anemia , cancer , clinical trial , chemotherapy
Programmed cell death protein 1 (PD-1) inhibitors have shown a therapeutic effect in the treatment of advanced cervical cancer in clinical trials. However, the clinical characteristics associated with response remain undetermined. This study aimed to evaluate the efficacy and prognostic factors of PD-1 inhibitors in patients with advanced cervical cancer in clinical practice.